Rapid testing has become central to the discussion about how to best tackle the current COVID-19 pandemic.
Read more
COVID-19 is a world-wide emergency with the first cases reported in December 2019 and more than 696,000 deaths and 18,000,000 cases of SARS-CoV-2 infection have been reported globally as of August 5th (WHO).
Read more
The COVID-19 pandemic has brought new attention to pulmonary diseases and associated biomarkers. Pneumonia and acute respiratory distress syndrome (ARDS) represented the most deadly conditions in COVID-19 patients leaving behind survivors suffering from lung fibrosis or other critical pulmonary complications. Below we will share with you a brief overview of protein & microRNA biomarkers that may be relevant to your pulmonary disease research or COVID-19 research.
Read more